ロード中...
Targeting DDX3 in Medulloblastoma Using the Small Molecule Inhibitor RK-33
Medulloblastoma is the most common malignant tumor that arises from the cerebellum of the central nervous system. Clinically, medulloblastomas are treated by surgery, radiation, and chemotherapy, all of which result in toxicity and morbidity. Recent reports have identified that DDX3, a member of the...
保存先:
| 出版年: | Transl Oncol |
|---|---|
| 主要な著者: | , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Neoplasia Press
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6171097/ https://ncbi.nlm.nih.gov/pubmed/30292066 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tranon.2018.09.002 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|